SIOFOR

This brand name is authorized in Albania, Croatia, Germany, Ireland, Poland, Romania.

Active ingredients

The drug SIOFOR contains one active pharmaceutical ingredient (API):

1	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SIOFOR Prolonged-release tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BA02	Metformin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	28/16, 29/16, 411/426
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02814149, 02814161, 06890561, 06890578, 07106233, 07106256
HR	Agencija za lijekove i medicinske proizvode	HR-H-217348720, HR-H-378441187, HR-H-386874224, HR-H-476992067, HR-H-523229726, HR-H-885679863
PL	Rejestru Produktów Leczniczych	100091011, 100091028, 100137055, 100398070, 100398086, 100398092, 100420130
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W42349001, W42349002, W42349003, W65728001, W65728002, W65728003, W65728004, W65728005, W65729001, W65729002, W65729003, W65729004, W65729005, W65730001, W65730002, W65730003, W65730004, W65730005